5 EASY FACTS ABOUT AGO TUMOR DESCRIBED

Molecular typing is predicated on molecular genetic testing and is not however routinely readily available. Molecular subtypes and immunohistochemical surrogate markers with the tumors (HR, HER2, triple adverse) correlate in about 70%. The differentiation of luminal A and B subtypes by HR status and proliferation markers like Ki-67 could be practic